| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
mutL homolog 1 | 0.399 | 0.808 | 3.4E-05 |
|
disease | 0.500 | None | 0.990 | 98 | 17 | 1988 | 2020 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.500 | None | 0.966 | 236 | 10 | 1991 | 2020 | ||||||||
|
mutS homolog 6 | 0.462 | 0.731 | 3.7E-05 |
|
disease | 0.200 | None | 0.964 | 28 | 10 | 1998 | 2020 | ||||||||
|
calcium sensing receptor | 0.410 | 0.846 | 4.7E-02 |
|
disease | 0.100 | None | 1.000 | 11 | 10 | 2008 | 2017 | ||||||||
|
APC regulator of WNT signaling pathway | 0.373 | 0.962 | 1.00 |
|
disease | 0.500 | None | 0.948 | 97 | 9 | 1992 | 2019 | ||||||||
|
F-box protein 11 | 0.604 | 0.692 | 1.00 |
|
disease | 0.100 | None | 1.000 | 2 | 9 | 2012 | 2013 | ||||||||
|
mutS homolog 2 | 0.406 | 0.808 | 0.90 |
|
disease | 0.200 | None | 0.981 | 54 | 8 | 1988 | 2019 | ||||||||
|
SMAD family member 7 | 0.470 | 0.769 | 0.55 |
|
disease | 0.160 | None | 1.000 | 23 | 8 | 2007 | 2019 | ||||||||
|
prostate cancer associated transcript 1 | 0.575 | 0.615 |
|
disease | 0.100 | None | 1.000 | 18 | 8 | 2007 | 2019 | |||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
disease | 0.400 | None | 0.971 | 104 | 6 | 2003 | 2019 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
disease | 0.400 | None | 0.979 | 97 | 6 | 1989 | 2019 | ||||||||
|
POU class 5 homeobox 1B | 0.670 | 0.346 | 2.9E-04 |
|
disease | 0.100 | None | 1.000 | 18 | 6 | 2007 | 2019 | ||||||||
|
cancer susceptibility 8 | 0.670 | 0.462 |
|
disease | 0.100 | None | 1.000 | 18 | 6 | 2007 | 2019 | |||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
disease | 0.500 | None | 0.981 | 154 | 5 | 1991 | 2019 | ||||||||
|
methylenetetrahydrofolate reductase | 0.337 | 0.885 | 3.2E-10 |
|
disease | 0.400 | None | 0.957 | 23 | 5 | 1999 | 2015 | ||||||||
|
PMS1 homolog 2, mismatch repair system component | 0.484 | 0.808 | 4.5E-27 |
|
disease | 0.200 | None | 1.000 | 16 | 5 | 2011 | 2019 | ||||||||
|
cytochrome P450 family 24 subfamily A member 1 | 0.518 | 0.692 | 3.2E-23 |
|
disease | 0.040 | None | 1.000 | 4 | 5 | 2001 | 2011 | ||||||||
|
inhibitor of nuclear factor kappa B kinase subunit beta | 0.506 | 0.846 | 0.99 |
|
disease | 0.210 | None | 1.000 | 2 | 5 | 2010 | 2010 | ||||||||
|
peroxisome proliferator activated receptor gamma | 0.358 | 0.885 | 2.9E-02 |
|
disease | 0.600 | None | 1.000 | 43 | 4 | 1998 | 2019 | ||||||||
|
mutY DNA glycosylase | 0.521 | 0.769 | 1.3E-18 |
|
disease | 0.500 | None | 1.000 | 12 | 4 | 2005 | 2018 | ||||||||
|
interleukin 17A | 0.324 | 0.923 | 4.3E-02 |
|
disease | 0.100 | None | 1.000 | 10 | 4 | 2013 | 2019 | ||||||||
|
estrogen receptor 1 | 0.324 | 0.962 | 1.00 |
|
disease | 0.090 | None | 1.000 | 9 | 4 | 2001 | 2019 | ||||||||
|
chromosome 5 open reading frame 66 | 0.760 | 0.154 | 5.3E-04 |
|
disease | 0.100 | None | 1.000 | 7 | 4 | 2013 | 2019 | ||||||||
|
CCND2 antisense RNA 1 | 0.760 | 0.154 |
|
disease | 0.100 | None | 1.000 | 7 | 4 | 2013 | 2019 | |||||||||
|
vesicle transport through interaction with t-SNAREs 1A | 0.674 | 0.154 | 5.4E-04 |
|
disease | 0.110 | None | 1.000 | 7 | 4 | 2014 | 2019 |